The Graduate Training Program in Molecular and Cellular Pharmacology at Stony Brook University trains Ph.D. students in the broad area of cell and molecular biology for careers in academia, government and industry. The Program is based in the Department of Pharmacological Sciences in the School of Medicine at SUNY-Stony Brook, but has an interdepartmental faculty including 64 potential mentors, 35 of whom are from other University Departments or the nearby Cold Spring Harbor Laboratory and Brookhaven National Laboratories. Students take courses in biochemistry, computational and cell biology, physiology and molecular genetics in the first year, with pharmacology and elective courses in the second year. The curriculum includes advanced courses in Neuropharmacology (including signal transduction), in Drug Design and DNA Damage, Repair and Carcinogenesis. Faculty members have been recruited to the Training Program to strengthen these areas. The training environment includes an active seminar series and participation in research symposia and minicourses. Training also involves experience teaching in courses offered to undergraduate majors in pharmacology. First year students participate in three laboratory rotations to prepare them to undertake dissertation research in any of the laboratories of the Training Program Faculty. The Training Program has trained 119 Ph.D. students in its 37-year history, and has 31 current trainees. The presence of seven underrepresented minority and 2 underprivileged students in the Program attests to a successful effort to recruit minority applicants.
The Molecular and Cellular Pharmacology training program provides graduate students with a solid background in the discipline of Pharmacology by bringing together training faculty from different research fields involved in the discovery, development and use of therapeutic compounds, offering courses both in the basic principles and systems pharmacology and by providing opportunities to the students to present their research in national and international meetings. The training grant supports the students early during their training (1st and sometimes 2nd year), aids in the recruitment and retention of diverse students and supports training in responsible conduct in research.
|Lewis, Crystal S; Torres, Luisa; Miyauchi, Jeremy T et al. (2016) Absence of Cytotoxicity towards Microglia of Iron Oxide (Î±-Fe2O3) Nanorhombohedra. Toxicol Res (Camb) 5:836-847|
|Torres, Luisa; Danver, Joan; Ji, Kyungmin et al. (2016) Dynamic microglial modulation of spatial learning and social behavior. Brain Behav Immun 55:6-16|
|Miyauchi, Jeremy T; Chen, Danling; Choi, Matthew et al. (2016) Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression. Oncotarget 7:9801-14|
|Burak, Matthew J; Guja, Kip E; Garcia-Diaz, Miguel (2015) Nucleotide binding interactions modulate dNTP selectivity and facilitate 8-oxo-dGTP incorporation by DNA polymerase lambda. Nucleic Acids Res 43:8089-99|
|QuiÃ±ones, Jason L; Thapar, Upasna; Yu, Kefei et al. (2015) Enzyme mechanism-based, oxidative DNA-protein cross-links formed with DNA polymerase Î² in vivo. Proc Natl Acad Sci U S A 112:8602-7|
|Montal, Emily D; Dewi, Ruby; Bhalla, Kavita et al. (2015) PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth. Mol Cell 60:571-83|
|Yang, Meng; Lu, Rui; Guja, Kip E et al. (2015) Unraveling Cholesterol Catabolism in Mycobacterium tuberculosis: ChsE4-ChsE5 Î±2Î²2 Acyl-CoA Dehydrogenase Initiates Î²-Oxidation of 3-Oxo-cholest-4-en-26-oyl CoA. ACS Infect Dis 1:110-125|
|Wang, Kai; Xu, Ruijuan; Schrandt, Jennifer et al. (2015) Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain. PLoS Genet 11:e1005591|
|Cathcart, Jillian; Pulkoski-Gross, Ashleigh; Cao, Jian (2015) Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas. Genes Dis 2:26-34|
|Salama, Mohamed F; Carroll, Brittany; Adada, Mohamad et al. (2015) A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. FASEB J 29:2803-13|
Showing the most recent 10 out of 60 publications